Your browser doesn't support javascript.
loading
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia.
Jacoby, Elad; Bielorai, Bella; Avigdor, Abraham; Itzhaki, Orit; Hutt, Daphna; Nussboim, Vered; Meir, Amilia; Kubi, Adva; Levy, Michal; Zikich, Dragoslav; Zeltzer, Li-At; Brezinger, Karin; Schachter, Jacob; Nagler, Arnon; Besser, Michal J; Toren, Amos.
Afiliación
  • Jacoby E; Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Bielorai B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Avigdor A; Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Itzhaki O; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hutt D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Nussboim V; Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Israel.
  • Meir A; Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel Hashomer, Israel.
  • Kubi A; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
  • Levy M; Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Zikich D; Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Zeltzer LA; Division of Pediatric Hematology and Oncology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel.
  • Brezinger K; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
  • Schachter J; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
  • Nagler A; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
  • Besser MJ; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
  • Toren A; Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Tel Hashomer, Israel.
Am J Hematol ; 93(12): 1485-1492, 2018 12.
Article en En | MEDLINE | ID: mdl-30187944
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2018 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2018 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos